Literature DB >> 34592931

Looking for consistency in an uncertain world: test-retest reliability of neurophysiological and behavioral readouts in autism.

Shlomit Beker1,2, John J Foxe1,2,3, John Venticinque4, Juliana Bates1, Elizabeth M Ridgeway1, Roseann C Schaaf5, Sophie Molholm6,7,8,9.   

Abstract

BACKGROUND: Autism spectrum disorders (ASD) are associated with altered sensory processing and perception. Scalp recordings of electrical brain activity time-locked to sensory events (event-related potentials; ERPs) provide precise information on the time-course of related altered neural activity, and can be used to model the cortical loci of the underlying neural networks. Establishing the test-retest reliability of these sensory brain responses in ASD is critical to their use as biomarkers of neural dysfunction in this population.
METHODS: EEG and behavioral data were acquired from 33 children diagnosed with ASD aged 6-9.4 years old, while they performed a child-friendly task at two different time-points, separated by an average of 5.2 months. In two blocked conditions, participants responded to the occurrence of an auditory target that was either preceded or not by repeating visual stimuli. Intraclass correlation coefficients (ICCs) were used to assess test-retest reliability of measures of sensory (auditory and visual) ERPs and performance, for the two experimental conditions. To assess the degree of reliability of the variability of responses within individuals, this analysis was performed on the variance of the measurements, in addition to their means. This yielded a total of 24 measures for which ICCs were calculated.
RESULTS: The data yielded significant good ICC values for 10 of the 24 measurements. These spanned across behavioral and ERPs data, experimental conditions, and mean as well as variance measures. Measures of the visual evoked responses accounted for a disproportionately large number of the significant ICCs; follow-up analyses suggested that the contribution of a greater number of trials to the visual compared to the auditory ERP partially accounted for this.
CONCLUSIONS: This analysis reveals that sensory ERPs and related behavior can be highly reliable across multiple measurement time-points in ASD. The data further suggest that the inter-trial and inter-participant variability reported in the ASD literature likely represents replicable individual participant neural processing differences. The stability of these neuronal readouts supports their use as biomarkers in clinical and translational studies on ASD. Given the minimum interval between test/retest sessions across our cohort, we also conclude that for the tested age-range of ~ 6 to 9.4 years, these reliability measures are valid for at least a 3-month interval. Limitations related to EEG task demands and study length in the context of a clinical trial are considered.
© 2021. The Author(s).

Entities:  

Keywords:  ASD; Biomarkers; EEG; ERP; ICC; Inter-trial variability

Mesh:

Year:  2021        PMID: 34592931      PMCID: PMC8483424          DOI: 10.1186/s11689-021-09383-0

Source DB:  PubMed          Journal:  J Neurodev Disord        ISSN: 1866-1947            Impact factor:   4.025


  73 in total

1.  Discovering translational biomarkers in neurodevelopmental disorders.

Authors:  Mustafa Sahin; Stephanie R Jones; John A Sweeney; Elizabeth Berry-Kravis; Barry W Connors; Joshua B Ewen; Adam L Hartman; April R Levin; William Z Potter; Laura A Mamounas
Journal:  Nat Rev Drug Discov       Date:  2018-12-20       Impact factor: 84.694

Review 2.  Intraclass correlations: uses in assessing rater reliability.

Authors:  P E Shrout; J L Fleiss
Journal:  Psychol Bull       Date:  1979-03       Impact factor: 17.737

3.  Reversal of age-related neural timing delays with training.

Authors:  Samira Anderson; Travis White-Schwoch; Alexandra Parbery-Clark; Nina Kraus
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

4.  Spherical splines for scalp potential and current density mapping.

Authors:  F Perrin; J Pernier; O Bertrand; J F Echallier
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1989-02

5.  Variable sensory perception in autism.

Authors:  Sarah M Haigh
Journal:  Eur J Neurosci       Date:  2017-05-25       Impact factor: 3.386

6.  Deficient auditory processing in children with Asperger Syndrome, as indexed by event-related potentials.

Authors:  Eira Jansson-Verkasalo; Rita Ceponiene; Marko Kielinen; Kalervo Suominen; Ville Jäntti; Sirkka Liisa Linna; Irma Moilanen; Risto Näätänen
Journal:  Neurosci Lett       Date:  2003-03-06       Impact factor: 3.046

7.  MEG detection of delayed auditory evoked responses in autism spectrum disorders: towards an imaging biomarker for autism.

Authors:  Timothy P L Roberts; Sarah Y Khan; Mike Rey; Justin F Monroe; Katelyn Cannon; Lisa Blaskey; Sarah Woldoff; Saba Qasmieh; Mike Gandal; Gwen L Schmidt; Deborah M Zarnow; Susan E Levy; J Christopher Edgar
Journal:  Autism Res       Date:  2010-02       Impact factor: 5.216

8.  Cortical cross-frequency coupling predicts perceptual outcomes.

Authors:  I C Fiebelkorn; A C Snyder; M R Mercier; J S Butler; S Molholm; J J Foxe
Journal:  Neuroimage       Date:  2012-11-24       Impact factor: 6.556

9.  Atypical processing of tones and phonemes in Rett Syndrome as biomarkers of disease progression.

Authors:  Olga V Sysoeva; Sophie Molholm; Aleksandra Djukic; Hans-Peter Frey; John J Foxe
Journal:  Transl Psychiatry       Date:  2020-06-10       Impact factor: 6.222

10.  Cortical Auditory Processing of Simple Stimuli Is Altered in Autism: A Meta-analysis of Auditory Evoked Responses.

Authors:  Zachary J Williams; Peter G Abdelmessih; Alexandra P Key; Tiffany G Woynaroski
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-09-22
View more
  1 in total

1.  Attentional influences on neural processing of biological motion in typically developing children and those on the autism spectrum.

Authors:  Emily J Knight; Aaron I Krakowski; Edward G Freedman; John S Butler; Sophie Molholm; John J Foxe
Journal:  Mol Autism       Date:  2022-07-18       Impact factor: 6.476

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.